Cell Reports Medicine · 17 Nov 2026
A phase 2, open-label, single-arm clinical trial of the safety and efficacy of the JAK1/3 inhibitor tofacitinib in Down syndrome
Angela L. Rachubinski, Emily Gurnee, Elizabeth B. Wallace, Belinda A. Enriquez Estrada, Kayleigh R. Worek, Rachel M. Shropshire, Bellina P. Guerra, Sitlali Flores Garcia, Pamela Navarette, Keith P. Smith, Ross E. Granrath, Brian F. Niemeyer, Eleanor C. Britton, Hannah R. Lyford, Madelaine Hipp, Ashley Snell, Neetha P. Eduthan, Micah G. Donovan, Kaylyn Van Deusen, Linda K. Roan, Abigail M. McKenzie, Amanda A. Hill, Barry Martin, Kelly D. Sullivan, Cory A. Dunnick, David A. Norris, Deborah J. Fidler, Lina R. Patel, Matthew D. Galbraith, Anna L. Bruckner, Joaquin M. Espinosah-index 20
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
No abstract is available for this paper.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Joaquin M. Espinosa has the highest h-index among the authors (20).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (95)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 75 more references
A free account opens the rest of the citing papers and references on every paper’s page.